NCT02646566View on ClinicalTrials.gov

Study of APD421 as PONV Treatment (Prior Prophylaxis)

PHASE3CompletedINTERVENTIONAL
Enrollment

705

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

APD421

DRUG

Placebo

Trial Locations (8)

27157

Wake Forest University School of Medicine, Winston-Salem

27710

Duke University Medical Center, Durham

33136

Jackson Memorial Hospital, Miami

43210

Ohio State University, Columbus

Unknown

CHU de Hautepierre, Strasbourg

Universität Heidelberg, Heidelberg

Philipps University, Marburg

08280

HELIOS Klinikum Aue, Aue

Sponsors

Lead Sponsor

Acacia Pharma Ltd
All Listed Sponsors
lead

Acacia Pharma Ltd

INDUSTRY